Olysio

Active Ingredient(s): Simeprevir
FDA Approved: * November 22, 2013
Pharm Company: * JANSSEN RES AND DEV
Category: Hepatitis

Simeprevir, sold under the trade names Olysio among others, is a medication used in combination with other medications for the treatment of hepatitis C.[1] It is specifically used for hepatitis C genotype 1 and 4.[1] Medications it is used with include sofosbuvir or ribavirin and peginterferon-alfa.[1] Cure rates are in 80s to 90s percent.[2][3][4] It may be used in those who also have HIV/AIDS.&am... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Olysio 150 mg/1 Oral Capsule

NDC: 59676-225

Labeler:

Janssen Products Lp